marc paul girard
Université Paris Cité
Paris, France
Review Editor
Vaccines and Molecular Therapeutics
Université Paris Cité
Paris, France
Review Editor
Vaccines and Molecular Therapeutics
Translational Health Science and Technology Institute (THSTI)
Faridabad, India
Review Editor
Vaccines and Molecular Therapeutics
IIBBA-CONICET Leloir Institute Foundation
Buenos Aires, Argentina
Review Editor
Vaccines and Molecular Therapeutics
Laboratory of Vaccine Development, Butantan Institute
SAO PAULO, Brazil
Review Editor
Vaccines and Molecular Therapeutics
University of Antioquia
MedellĂn, Colombia
Review Editor
Vaccines and Molecular Therapeutics
W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University
Baltimore, United States
Review Editor
Vaccines and Molecular Therapeutics
INSERM U1068 Centre de Recherche en Cancérologie de Marseille (CRCM)
Marseille, France
Review Editor
Vaccines and Molecular Therapeutics
Stanford University
Stanford, United States
Review Editor
Vaccines and Molecular Therapeutics
University of Erlangen Nuremberg
Erlangen, Germany
Review Editor
Vaccines and Molecular Therapeutics
The University of Iowa
Iowa City, United States
Review Editor
Vaccines and Molecular Therapeutics
University of Oslo
Oslo, Norway
Review Editor
Vaccines and Molecular Therapeutics
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Vaccines and Molecular Therapeutics
Federal University of Paraná
Curitiba, Brazil
Review Editor
Vaccines and Molecular Therapeutics
University of California, San Francisco
San Francisco, United States
Review Editor
Vaccines and Molecular Therapeutics
National University of Singapore
Singapore, Singapore
Review Editor
Vaccines and Molecular Therapeutics
University of Oslo
Oslo, Norway
Review Editor
Vaccines and Molecular Therapeutics